Bicara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	96.69	489.71	230.44	4.16
Short-Term Investments	318.12	-	-	-
Cash & Short-Term Investments	414.8	489.71	230.44	4.16
Cash Growth	-15.30%	112.51%	5442.09%	-
Other Current Assets	7.25	12.82	0.63	0.83
Total Current Assets	422.05	502.53	231.07	4.98
Net Property, Plant & Equipment	2.03	0.85	0.82	0.64
Other Long-Term Assets	6.91	6.62	2.09	1.08
Total Assets	430.99	510	233.98	6.7
Accounts Payable	7.79	4.51	3.19	5.14
Accrued Expenses	20.04	12.88	11.61	18.76
Current Portion of Leases	1.12	0.61	0.29	-
Total Current Liabilities	28.95	17.99	15.09	23.9
Long-Term Leases	0.59	0.13	0.37	-
Other Long-Term Liabilities	-	-	0.02	0.09
Total Long-Term Liabilities	0.59	0.13	0.39	0.09
Total Liabilities	29.54	18.12	15.47	23.98
Common Stock	0.01	0.01	0	0
Additional Paid-in Capital	760.17	712.88	4.25	2.23
Accumulated Other Comprehensive Income	0.24	-	-	-
Retained Earnings	-358.97	-221.02	-153.02	-101.04
Total Common Shareholders' Equity	401.45	491.88	-148.77	-98.8
Minority Interest	-	-	367.28	81.53
Shareholders' Equity	401.45	491.88	218.51	-17.28
Total Liabilities & Equity	430.99	510	233.98	6.7
Total Debt	1.71	0.74	0.66	0
Net Cash (Debt)	413.09	488.97	229.78	4.16
Net Cash Growth	-15.52%	112.80%	5426.29%	-
Net Cash Per Share	7.55	29.10	396.10	9.69
Book Value	401.45	491.88	-148.77	-98.8
Book Value Per Share	7.34	29.27	-256.45	-230.26
Tangible Book Value	401.45	491.88	-148.77	-98.8
Tangible Book Value Per Share	7.34	29.27	-256.45	-230.26

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q